Senior Director, North America Marketing Rare Diseases

Overview

The Senior Director, North America Marketing will set up and refine the marketing strategies in the US & Canada for GIVLAARI & OXLUMO and will lead the NA Marketing Team to develop and execute impactful initiatives directed to health-care professionals and patients.

This is a pivotal position within the Global Rare Business Unit, and a core member of the North America region leadership team. The role requires establishing productive partnerships with other functions at Alnylam, and to develop a high-performing marketing team focused on results.

We are looking for a driven, highly collaborative and humble individual, who is committed to people, people development and cross-functional partnership. This role will report to the VP, Marketing & Programs for Rare Diseases. This is a hybrid position that requires regular attendance at Alnylam HQ located in Cambridge, MA.

Key Responsibilities

• Develop and execute HCP & Patient commercialization strategies across multiple brands in different therapeutic areas in collaboration with cross-functional stakeholders - inclusive of the sales, business ops, customer insights and market access
  
• Drive US insights into Acute Hepatic Porphyria and Primary Hyperoxaluria therapeutic areas through customer interactions and working with Market Research.
  
• Identify, strategize, plan and execute incremental growth opportunities for the different brands in the US and Canada markets
  
• Create and implement innovative market development, diagnostic and competitive strategies for the US and Canada markets

• Execute US-focused HCP engagement and patient initiatives in collaboration with medical affairs patient advocacy. Cultivate and maintain strong relationships with local and national key opinion leaders (KOLs) within the disease areas
  
• Lead and develop the North America marketing team to achieve high performance and maximize potential aligned with company values
  
• Develop and maintain strong relationships deep within other functional areas and internal strategic partners (i.e. Medical Affairs, Patient Services, etc.)
  
• Collaborate with legal, regulatory, and compliance stakeholders to ensure compliant development and execution of marketing initiatives
  

Qualifications

• Bachelor of Science or Arts required; MBA preferred
  
• 12+ years of commercial and/or marketing experience in the US pharmaceutical or biotech industry, with experience in managing rare disease products
  
• Proven experience in developing HCP and Patient Marketing strategies and tactics that have delivered strong commercial results, including in competitive markets
  
• Experience in preparing and delivering senior level presentations and communication with executive presence
  
• Proven people and leadership skills and the ability to collaborate in a matrix environment

About Alnylam:Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by "interfering" with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.

Our culture:Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we've been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2023 for the third consecutive year, one of Science Magazine's Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK - among others.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients. Qualified applicants will receive consideration for employment without regard to their race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, ethnicity, marital status, protected veteran status, disability, or any other characteristics prohibited by law.